AIM ImmunoTech, Inc. (AIM)

1.175 -0.16 (-12.31%) USD  |  NYAM  |  Jan 20, 16:00
1.20 +0.02 (+2.13%) After-Hours: 19:28
More

AIM ImmunoTech Average Diluted Shares Outstanding (Semi Annual)

Average Diluted Shares Outstanding (Semi Annual) Chart

View Average Diluted Shares Outstanding (Semi Annual) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Semi Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Semi Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Semi Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Semi Annual) Benchmarks

View Average Diluted Shares Outstanding (Semi Annual) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. --
Perspective Therapeutics, Inc. --
Protalix Biotherapeutics, Inc. --
Electromed, Inc. --
Armata Pharmaceuticals, Inc. --